Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judson

Showing results (1121-1130 of 2,335) with videos related to

Pageof 234
Sort By:
American Journal of Clinical Oncology|November 3, 2015
Successful Ifosfamide Rechallenge in Soft-Tissue SarcomaJonathan Noujaim, Anastasia Constantinidou, Christina Messiou, et al.
Vital and Health Statistics. Ser. 1, Programs and Collection Procedures|September 17, 2015
Linkage of NCHS Population Health Surveys to Administrative Records From Social Security Administration and Centers for Medicare Medicaid ServicesCordell Golden, Anne K Driscoll, Alan E Simon, et al.
Tropical Doctor|May 6, 2025
Primary spontaneous colporrhexis in a primigravidaEunice Susanna Abraham, Ashwin Sukumar, Arpit Jacob Mathew, et al.
Urology|February 5, 2013
Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric studyJudson D Davies, Christopher M Simons, Nedim Ruhotina, et al.
Human Genetics|June 1, 2000
Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor geneH Judson, N van Roy, L Strain, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcomaH M Coley, M W Verrill, S E Gregson, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Expert Review of Anticancer Therapy|November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanibChristopher P Wilding, Mark L Elms, Ian Judson, et al.
The Journal of Reproductive Medicine|February 7, 2008
Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role?Peter A Argenta, Rebekah R Ormsby, Levi S Downs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignanciesCharlotte Rees, P Beale, Jose Manuel Trigo, et al.
Pageof 234

Showing results (1121-1130 of 2,335) with videos related to

Sort By:
Pageof 234
American Journal of Clinical Oncology|November 3, 2015
Successful Ifosfamide Rechallenge in Soft-Tissue SarcomaJonathan Noujaim, Anastasia Constantinidou, Christina Messiou, et al.
Vital and Health Statistics. Ser. 1, Programs and Collection Procedures|September 17, 2015
Linkage of NCHS Population Health Surveys to Administrative Records From Social Security Administration and Centers for Medicare Medicaid ServicesCordell Golden, Anne K Driscoll, Alan E Simon, et al.
Tropical Doctor|May 6, 2025
Primary spontaneous colporrhexis in a primigravidaEunice Susanna Abraham, Ashwin Sukumar, Arpit Jacob Mathew, et al.
Urology|February 5, 2013
Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric studyJudson D Davies, Christopher M Simons, Nedim Ruhotina, et al.
Human Genetics|June 1, 2000
Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor geneH Judson, N van Roy, L Strain, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcomaH M Coley, M W Verrill, S E Gregson, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Expert Review of Anticancer Therapy|November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanibChristopher P Wilding, Mark L Elms, Ian Judson, et al.
The Journal of Reproductive Medicine|February 7, 2008
Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role?Peter A Argenta, Rebekah R Ormsby, Levi S Downs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignanciesCharlotte Rees, P Beale, Jose Manuel Trigo, et al.
Pageof 234